Wordt geladen...
Successful Discontinuation of Infliximab in a Refractory Case of Vasculo-Behçet Disease
Reports have shown that antitumor necrosis factor alpha (anti-TNF-α) agents including infliximab (IFX) can dramatically suppress the disease activity of refractory vasculo-Behçet disease (vasculo-BD). However, it is completely unknown whether we can discontinue anti-TNF-α agents under clinical remis...
Bewaard in:
| Gepubliceerd in: | Case Rep Rheumatol |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Hindawi Publishing Corporation
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808526/ https://ncbi.nlm.nih.gov/pubmed/27034879 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/1467583 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|